Scartozzi M - Search Results

1

Tracking the 2015 Gastrointestinal Cancers Symposium: bridging cancer biology to clinical gastrointestinal oncology.

Aprile G, Leone F, Giampieri R, Casagrande M, Marino D, Faloppi L, Cascinu S, Fasola G, Scartozzi M. Aprile G, et al. Among authors: scartozzi m. Onco Targets Ther. 2015 May 22;8:1149-56. doi: 10.2147/OTT.S82624. eCollection 2015. Onco Targets Ther. 2015. PMID: 26045669 Free PMC article. Review.

2

Liver metastases from colorectal cancer.

Cascinu S, Catalano V, Scartozzi M, Baldelli AM, Cellerino R. Cascinu S, et al. Among authors: scartozzi m. Ann Oncol. 1997 Apr;8(4):393-9. doi: 10.1023/a:1008232421790. Ann Oncol. 1997. PMID: 9209671 Free article. No abstract available.

3

Adjuvant chemotherapy in gastric cancer. The Italian experience and review of the literature.

Berardi R, Scartozzi M, Galizia E, Cascinu S. Berardi R, et al. Among authors: scartozzi m. Suppl Tumori. 2003 Sep-Oct;2(5):S45-7. Suppl Tumori. 2003. PMID: 12914390 Review.

4

Gastric cancer treatment: a systematic review.

Berardi R, Scartozzi M, Romagnoli E, Antognoli S, Cascinu S. Berardi R, et al. Among authors: scartozzi m. Oncol Rep. 2004 Apr;11(4):911-6. Oncol Rep. 2004. PMID: 15010894 Review.

5

[Non-small cell lung carcinoma: pathology, biology and prognosis].

Freddari F, Berardi R, Scartozzi M, Cascinu S. Freddari F, et al. Among authors: scartozzi m. Suppl Tumori. 2004 Mar-Apr;3(2):S3-4. Suppl Tumori. 2004. PMID: 15067954 Italian. No abstract available.

6

Molecular biology of sporadic gastric cancer: prognostic indicators and novel therapeutic approaches.

Scartozzi M, Galizia E, Freddari F, Berardi R, Cellerino R, Cascinu S. Scartozzi M, et al. Cancer Treat Rev. 2004 Aug;30(5):451-9. doi: 10.1016/j.ctrv.2004.01.001. Cancer Treat Rev. 2004. PMID: 15245777 Review.

7

A cost-benefit analysis of chemotherapy for gastric cancer.

Galizia E, Berardi R, Scartozzi M, Cascinu S. Galizia E, et al. Among authors: scartozzi m. Expert Opin Pharmacother. 2004 Oct;5(10):2109-14. doi: 10.1517/14656566.5.10.2109. Expert Opin Pharmacother. 2004. PMID: 15461546 Review.

8

Epidermal growth factor receptor (EGFR) status in primary colorectal tumors does not correlate with EGFR expression in related metastatic sites: implications for treatment with EGFR-targeted monoclonal antibodies.

Scartozzi M, Bearzi I, Berardi R, Mandolesi A, Fabris G, Cascinu S. Scartozzi M, et al. J Clin Oncol. 2004 Dec 1;22(23):4772-8. doi: 10.1200/JCO.2004.00.117. J Clin Oncol. 2004. PMID: 15570078

9

New frontiers in the neoadjuvant therapy of pancreatic adenocarcinoma: apart from therapeutical protocols.

Berardi R, Verdecchia L, Scartozzi M, Cascinu S. Berardi R, et al. Among authors: scartozzi m. JOP. 2005 Jan 13;6(1 Suppl):118-21. JOP. 2005. PMID: 15650296 Review. No abstract available.

10

Over-DI dissection may question the value of radiotherapy as a part of an adjuvant programme in high-risk radically resected gastric cancer patients.

Scartozzi M, Galizia E, Graziano F, Catalano V, Berardi R, Baldelli AM, Testa E, Mari D, Silva RR, Cascinu S. Scartozzi M, et al. Br J Cancer. 2005 Mar 28;92(6):1051-4. doi: 10.1038/sj.bjc.6602468. Br J Cancer. 2005. PMID: 15770210 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

358 results

Search Page